摘要
HomeCirculationVol. 148, No. 15Cardiac Troponins for Diagnosis and Prognostic Assessment of Immune Checkpoint Inhibitor Myocarditis and Myositis: The Emerging Importance of Peripheral Vision No AccessArticle CommentaryRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessArticle CommentaryRequest AccessFull TextCardiac Troponins for Diagnosis and Prognostic Assessment of Immune Checkpoint Inhibitor Myocarditis and Myositis: The Emerging Importance of Peripheral Vision Christopher deFilippi and Ana Barac Christopher deFilippiChristopher deFilippi Correspondence to: Christopher deFilippi, MD, Inova Schar Heart and Vascular, Ste 1225, 3300 Gallows Rd, Falls Church, VA 22042. Email E-mail Address: [email protected] https://orcid.org/0000-0002-0660-4943 Inova Schar Heart and Vascular, Falls Church, VA. Search for more papers by this author and Ana BaracAna Barac https://orcid.org/0000-0002-9935-8904 Inova Schar Heart and Vascular, Falls Church, VA. Search for more papers by this author Originally published9 Oct 2023https://doi.org/10.1161/CIRCULATIONAHA.123.065988Circulation. 2023;148:1135–1137FootnotesThe opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.For Sources of Funding and Disclosures, see page 1137.Circulation is available at www.ahajournals.org/journal/circCorrespondence to: Christopher deFilippi, MD, Inova Schar Heart and Vascular, Ste 1225, 3300 Gallows Rd, Falls Church, VA 22042. Email Christopher.Defilippi@Inova.orgREFERENCES1. Haslam A, Gill J, Prasad V. Estimation of the percentage of US patients with cancer who are eligible for immune checkpoint inhibitor drugs.JAMA Netw Open. 2020; 3:e200423. doi: 10.1001/jamanetworkopen.2020.0423CrossrefMedlineGoogle Scholar2. Brahmer JR, Abu-Sbeih H, Ascierto PA, Brufsky J, Cappelli LC, Cortazar FB, Gerber DE, Hamad L, Hansen E, Johnson DB, et al. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events.J ImmunoTher Cancer. 2021; 9:e002435. doi: 10.1136/jitc-2021-002435CrossrefMedlineGoogle Scholar3. Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, et al; ESC Scientific Document Group. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).Eur Heart J. 2022; 43:4229–4361. doi: 10.1093/eurheartj/ehac244CrossrefMedlineGoogle Scholar4. Lehmann LH, Heckmann MB, Bailly G, Finke D, Procureur A, Power JR, Stein F, Bretagne M, Ederhy S, Fenioux C, et al. Cardiomuscular biomarkers in the diagnosis and prognostication of immune checkpoint inhibitor myocarditis.Circulation. 2023; 148:473–486. doi: 10.1161/CIRCULATIONAHA.123.062405LinkGoogle Scholar5. du Fay de Lavallaz J, Prepoudis A, Wendebourg MJ, Kesenheimer E, Kyburz D, Daikeler T, Haaf P, Wanschitz J, Löscher WN, Schreiner B, et al; BASEL XII Investigators. Skeletal muscle disorders: a noncardiac source of cardiac troponin T.Circulation. 2022; 145:1764–1779. doi: 10.1161/CIRCULATIONAHA.121.058489LinkGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetails October 10, 2023Vol 148, Issue 15 Advertisement Article InformationMetrics © 2023 American Heart Association, Inc.https://doi.org/10.1161/CIRCULATIONAHA.123.065988PMID: 37812655 Originally publishedOctober 9, 2023 Keywordstroponin Iimmune checkpoint inhibitorstroponin TmyocarditismyositisPDF download Advertisement SubjectsCardio-Oncology